ReviewCancers2022

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact.

Piera Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.